Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies

[1]  L. Oñate-Ocaña,et al.  Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement , 2007, Annals of Surgical Oncology.

[2]  M. Ducreux,et al.  Peritoneal carcinomatosis of colorectal origin. , 2006, Gastroenterologie clinique et biologique.

[3]  B. Moran,et al.  Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: a novel treatment strategy with promising results in selected patients , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[4]  Hyungjin Kim,et al.  Treatment of Peritoneal Carcinomatosis from Colorectal Cancer , 2006 .

[5]  G. Ortega-Pérez,et al.  Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  T. Seufferlein,et al.  Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  W. Oyen,et al.  Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies , 2006, Annals of surgery.

[8]  P. Sugarbaker,et al.  Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C , 2006, Cancer Chemotherapy and Pharmacology.

[9]  M. Ceranic,et al.  Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  P. Sugarbaker,et al.  Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. , 2005, The oncologist.

[11]  H. Schlitt,et al.  Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  M. Ducreux,et al.  Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  F. Kwiatkowski,et al.  Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  E. Cotte,et al.  Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin , 2004, The British journal of surgery.

[15]  K. Geisinger,et al.  Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy With Mitomycin C for Peritoneal Carcinomatosis from Nonappendiceal Colorectal Carcinoma , 2004, Annals of Surgical Oncology.

[16]  L. Påhlman,et al.  Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study , 2004, British Journal of Cancer.

[17]  A. Witkamp,et al.  Long-Term Survival of Peritoneal Carcinomatosis of Colorectal Origin , 2004, Annals of Surgical Oncology.

[18]  H. van Tinteren,et al.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  E. Cotte,et al.  Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure and Cytoreductive Surgery for the Treatment of Peritoneal Carcinomatosis: Morbidity and Mortality Analysis of 216 Consecutive Procedures , 2003, Annals of Surgical Oncology.

[20]  S. Mocellin,et al.  Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Intraoperative Chemotherapy for Peritoneal Carcinomatosis Arising From Colon Adenocarcinoma , 2003, Annals of Surgical Oncology.

[21]  F. Gilly,et al.  Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  P. Sugarbaker.  Carcinomatosis--is cure an option? , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  E. Levine,et al.  Long-Term Survivorship and Quality of Life After Cytoreductive Surgery Plus Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis , 2003, Annals of Surgical Oncology.

[24]  M. Ducreux,et al.  Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy , 2001, Cancer.

[25]  F. van Coevorden,et al.  Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. , 2001, European journal of cancer.

[26]  M. Manns,et al.  Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  J. Faure,et al.  Peritoneal carcinomatosis from non‐gynecologic malignancies , 2000, Cancer.

[28]  D. Elias,et al.  Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. , 2000, International journal of surgical investigation.

[29]  P. Sugarbaker,et al.  Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy , 1999, Annals of Surgical Oncology.

[30]  J. Esquivel,et al.  Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique , 1999, Annals of Surgical Oncology.

[31]  P. Sugarbaker.  Peritonectomy procedures. , 1996, Cancer treatment and research.

[32]  P. Sugarbaker,et al.  Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. , 1996, Cancer treatment and research.

[33]  K. Jablonski,et al.  Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy , 1995, Annals of surgery.

[34]  K. Westbrook,et al.  Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors , 1989, Cancer.

[35]  A. Recht,et al.  Potentially curative surgery of colon cancer: patterns of failure and survival. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.